Hypokalemia and sudden death may occur in severe megaloblastic anemia which is treated intensely
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F
Spironolactone is contraindicated in patients with hyperkalemia (high potassium), severe kidney disease, Addisons disease, or those taking certain medications (potassium supplements, ACE inhibitors, ARBs in high doses)
AOD 9604 is typically given as a once-daily subcutaneous injection (under the skin)
Research shows TMS can produce meaningful improvements in treatment-resistant depression, with studies reporting remission rates of 30-58% (Berlim et al., 2014
Do not use in animals with diarrhoea